2ESSB 5594
| Momentum Bucket | Strong Momentum |
| Legal Title | AN ACT Relating to reducing prescription drug costs by eliminating barriers impeding access to biosimilar medicines and interchangeable biological products; |
| Bill Description | Concerning biosimilar medicines. (REVISED FOR ENGROSSED: Concerning biosimilar medicines and interchangeable biological products.) |
|
What this bill does
Powered by Legitron |
Not available yet. |
|
Why it matters
Powered by Legitron |
Not available yet. |
| Official Documents | View Full Bill Text |
2ESSB 5594 Position - A premium account is required to save position information.
2ESSB 5594 Details and Bill Topics
Details
| Date Introduced | 02/18/2025 |
| Originating Chamber | Senate |
| Biennium | 2025-26 |
| Total Campaign Dollars Backing Bill | $3,614,058.00 |
Bill Topics
| HEALTH INSURANCE |
2ESSB 5594 Sponsors and Committee Hearings
Committee Hearings
| Hearing | Senate Health & Long-Term Care (Public) |
| Hearing | Senate Health & Long-Term Care (Executive) |
| Hearing | House Health Care & Wellness (Public) |
| Hearing | House Health Care & Wellness (Public) |
| Hearing | House Health Care & Wellness (Executive) |
2ESSB 5594 Bill Timeline
Strong Momentum
2/24/2026
SRules 3
Referred to Rules 2 Review.
2/24/2026
SRules 3
HCW - Majority; do pass.
2/24/2026
SRules 3
HCW - Executive action taken by committee.
1/20/2026
SRules 3
Returned to second reading for amendment.
1/20/2026
SRules 3
Rules suspended.
1/18/2026
SRules 3
Placed on third reading.
1/18/2026
SRules 3
Rules Committee relieved of further consideration.
1/11/2026
SRules 3
By resolution, reintroduced and retained in present status.
4/26/2025
SRules 3
By resolution, returned to Senate Rules Committee for third reading.
3/12/2025
SRules 3
First reading, referred to Health Care & Wellness.
3/10/2025
SRules 3
Third reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0.
3/10/2025
SRules 3
Rules suspended. Placed on Third Reading.
3/10/2025
SRules 3
Floor amendment(s) adopted.
3/10/2025
SRules 3
1st substitute bill substituted.
3/4/2025
SRules 3
Placed on second reading by Rules Committee.
2/18/2025
SRules 3
Passed to Rules Committee for second reading.
2/17/2025
SRules 3
HLTC - Majority; 1st substitute bill be substituted, do pass.
1/29/2025